NCT06145282 Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06098755 The Sequestration of Holistic Stress Management Techniques for Adults Status WITHDRAWN Phase NA
NCT06023199 Assessing Physical Function in Sickle Cell Patients Taking Voxelotor Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06016634 Alendronate for Osteonecrosis in Adults With Sickle Cell Disease Status RECRUITING Phase PHASE2
NCT05998824 COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease Status COMPLETED Phase NA
NCT05953584 A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke Status RECRUITING Phase PHASE2
NCT05951205 Evaluation of Efficacy and Safety of a Single Dose of Exa-cel in Participants With Severe Sickle Cell Disease, βS/ βC Genotype Status WITHDRAWN Phase PHASE3
NCT05909657 Enablers and Barriers to Hydroxyurea Use for Sickle Cell Disease Jamaica Status UNKNOWN Phase N/A
NCT05905770 Do Alemtuzumab Levels Predict T Cell Chimerism After MSD SCT for SCD? Status RECRUITING Phase N/A
NCT05904093 Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease Status RECRUITING Phase PHASE1
NCT05894161 Efficacy of Designed Exercise Program on Pain and Quality of Sleeping in Patient With Sickle Cell Disease Anemia. Status COMPLETED Phase NA
NCT05861453 Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT05848531 Clonidine With Morphine in Patient Controlled Analgesia Pump in Vaso-Occlusive Crisis in Sickle Cell Disease Patient Status UNKNOWN Phase PHASE4